Relationship of Sodium and Magnesium Intakes to Hypertension Proven by 24-Hour Urianalysis in a South Indian Population

Journal of Clinical Hypertension

Volumn 16, Issue 8, 2014, Pages 581-586

  Chidambaram, Natesan ^a   Sethupathy, Subramaniyam ^a   Saravanan, Nadanam ^a   Mori, Mari ^b   Yamori, Yukio ^b   Garg, Arun Kumar ^c   Chockalingam, Arun ^d  

^a ANNAMALAI UNIVERSITY   (India)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^c FRASER HEALTH AUTHORITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MAGNESIUM; SODIUM; BIOLOGICAL MARKER; SODIUM INTAKE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CONTROLLED STUDY; CREATININE URINE LEVEL; DIETARY INTAKE; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; FEMALE; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; INDIAN; MAGNESIUM URINE LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; SODIUM URINE LEVEL; URINALYSIS; ADVERSE EFFECTS; AGE; BLOOD; CIRCADIAN RHYTHM; COMPARATIVE STUDY; COMPLICATION; DIET; DRUG EFFECTS; INDIA; MAGNESIUM DEFICIENCY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SODIUM INTAKE; URINE;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CIRCADIAN RHYTHM; CREATININE; DIET; FEMALE; HUMANS; HYPERTENSION; INDIA; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; RISK FACTORS; SODIUM; SODIUM, DIETARY; URINALYSIS;

EID: 84905754517     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12361     Document Type: Article

References (63)

1. Lawes CM, Vander Hoorn S, Rodgers A. For the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518.
2. Indrayan A. Forecasting vascular disease cases and associated mortality in India 2007; http://www.whoindia.org/LinkFiles/CommisiononMacroeconomicandHealthBgP2ForecastingvasculardiseasecasesandassociatedmortalityinIndia.pdf. Accessed November 6, 2008.
3. Pella D, Thomas N, Tomlinson B, Singh RB. Prevention of coronary artery diseases: the South Asian paradox. Lancet. 2003;361:79.
4. American Heart Association Heart and Stroke Statistical Update, 2008. http://www.americanheart.org/downloadable/heart/1200078608862HSStats%202008.final.pdf. Accessed April 23, 2014.
5. Vlado P, Rachel H, Yangfeng W, et al. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension. 2007;50:991-997.
6. Forrester T, Cooper RS, Weatherall D. Emergence of Western diseases in the tropical world: the experience with chronic cardiovascular diseases. Br Med Bull. 1998;54:463-473.
7. Chockalingam A, Balaguer-Vintro I. Impending Global Pandemic of Cardiovascular Diseases: Challenges and Opportunities for the Prevention and Control of Cardiovascular Diseases in Developing Countries and Economies in Transition. Barcelona: The World Heart Federation, Prous Science; 1999.
8. Intersalt Cooperative Research Group. INTERSALT: An international study of electrolyte excretion and blood pressure: results for 24 h urinary sodium and potassium excretion. Br Med J. 1988;297:319-328.
9. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension. 2003;42:1093-1099.
10. World Health Organization (2007) WHO forum on reducing salt intake in populations: a report of a WHO forum and technical meeting, 5-7 October 2006, Paris, France, WHO, Geneva. http://www.who.int/dietphysicalactivity/Salt_Report_VC_april07.pdf. Accessed April 23, 2014.
11. National Institute of Nutrition. Dietary Guidelines for Indians - A Manual, 2nd ed. Hyderabad, India: National Institute of Nutrition; 2011.
12. Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr. 1997;65(suppl):626S-642S.
13. Hoosen S, Seedat YK, Bhigjee AI, et al. A study of urinary sodium and potassium excretion rates among urban and rural Zulus and Indians. J Hypeterns. 1985;3:351-358.
14. Yu Z, Song G, Gou Z, et al. Changes in blood pressure, body mass index and salt consumption in a Chinese population. Prev Med. 1999;29:165-172.
15. Wolf FI, Cittadini A. Chemistry and biochemistry of magnesium. Mol Aspects Med. 2003;24:3-9.
16. Liao F, Folsom AR, Brancati FL. "Is low magnesium concentration a risk factor for coronary heart disease?" The atherosclerosis risk in communities (ARIC) study. Am Heart J. 1998;136:480-490.
17. Peacock JM, Folsom AR, Arnett DK, et al. Relationship of serum dietary magnesium to incident hypertension: the atherosclerosis risk in communities (ARIC) study. Ann Epidemiol. 1999;9:159-165.
18. Ma J, Folsom AR, Melnick SL, et al. Association of serum and dietary magnesium with cardiovascular disease hypertension, diabetes, insulin and carotid arterial wall thickness: atherosclerosis risk in communities study. J Clin Epidemiology. 1995;48:927-940.
19. Jee SH, Miller ER, Guallar E, et al. The effect of magnesium supplementation on blood pressure: a metaanalysis of randomized clinical trials. Am J Hypertens. 2002;15:691-696.
20. He K, Liu K, Daviglus ML, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675-1682.
21. Excerpts from the WHO CARDIAC Study Protocol. J Cardiovasc Pharmacol. 1990;16(suppl 8):S75-S77.
22. Yamori L, Liu K, Ikeda A, et al. WHO-Cardiovascular Disease and Alimentary Comprarison (CARDIAC) Study Group. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res. 2001;24:453-457.
23. Yamori Y, Liu L, Mizushima S, et al. CARDIAC Study Group. Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens. 2006;24:1499-1505.
24. Smith-Warner SA, Elmer PJ, Tharp TM, et al. Increasing vegetable and fruit intake: randomized intervention and monitoring in an at-risk population. Cancer Epidemiol Biomarkers Prev. 2000;9:307-317.
25. Sorof JM, Forman A, Cole N, et al. Potassium intake and cardiovascular reactivity in children with risk factors for essential hypertension. J Pediatr. 1997;131:87-94.
26. Cardiovascular Diseases and Alimentary Comparison (CARDIAC) StudyCARDIAC Study Protocol and Manual of Operations. Shimane/Geneva: WHO Collaborating Centre on Primary Prevention of Cardiovascular Diseases. Cardiovascular Diseases Unit, WHO; 1986.
27. Yamori Y, Nara Y, Kihara M, et al. Simple method for sampling consecutive 24-hour urine for epidemiological and clinical studies. Clin Exp Hypertens A. 1984;6:1161-1167.
28. Yamori Y, Nara Y, Kihara M, Mano W, Horie R.Aliquot cups', simple method for collecting consecutive 24-hour urine samples for epidemiological and clinical studies. Nutritional Prevention of Cardiovascular Disease Orlando. Clin Exp Hypertens A. 1984;6:1161-1167.
29. Mizushima S, Moriguchi EH, Nakada Y, et al. The relationship of dietary factors to cardiovascular diseases among Japanese in Okinawa and Japanese immigrants, originally from Okinawa, in Brazil. Hypertens Res. 1992;15:45-55.
30. Nitin N, Simmi D, Ankur J, et al. Association of anthropometric indices of obesity with diabetes, hypertension and dyslipidemia: a study from central India. Indian J Med Specialities. 2012;3:6-11.
31. Hazarika NC, Biswas D, Narain K, et al. Hypertension and its risk factors in tea garden workers of Assam. Natl Med J India. 2002;15:63-68.
32. Prabhakaran D, Shah P, Chaturvedi V, et al. Cardiovascular risk factor prevalence among men in a large industry of northern India. Natl Med J India. 2005;18:59-65.
33. Mtabaji JP, Nara Y, Moriguchi Y, Yamori Y. Diet and hypertension in Tanzania. J Cardiovasc Pharmacol. 1990;8(suppl 20):S3-S8.
34. He J, Klag MJ, Whelton PK, et al. Migration, blood pressure and hypertension: the Yi migrant study. Am J Epidemiol. 1991;134:1085-1101.
35. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. Br Med J. 1995;311:158-161.
36. Singh RB, Ghosh S, Beegom R, et al. Prevalence and determinants of central obesity and age-specific waist/hip ratio of people in five cities: The Indian women's health study. J Cardiovasc Risk. 1998;5:73-77.
37. Gao M, Ikeda K, Hattori H, et al. Cardiovascular risk factors emerging in Chinese populations undergoing urbanization. Hypertens Res. 1999;22:209-215.
38. Yamori Y, Liu L, Mu L, et al; on behalf of the Japan-China Cooperative Study Group. Diet-related factors, educational levels and blood pressure in a Chinese population sample: findings from the Japan-China Cooperative Research Project. Hypertens Res. 2002;25:559-564.
39. Khan NA, McAlister FA, Rabkin SW, et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol. 2006;22:583-593.
40. James WP, Ralph A, Sanchez-Castillo CP. The dominance of salt in manufactured food in the sodium intake of affluent societies. Lancet. 1987;1:426-429.
41. Scientific Advisory Committee on Nutrition (2003) Salt and Health. London: The Stationery Office. http://www.sacn.gov.uk/pdfs/sacn_salt_final.pdf. Accessed April 23, 2014.
42. MacGregor G, de Wardener HE. Salt, blood pressure and health. Int J Epidemiol. 2002;31:320-327.
43. Chockalingam A, Balaguer-Vintro I, Achutti A, et al. The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. Can J Cardiol. 2000;16:227-229.
44. Antonios TF, MacGregor GA. Salt: more adverse effects. Lancet. 1996;348:250-251.
45. Perry IJ, Beevers DG. Salt intake and stroke: a possible direct effect. J Hum Hypertens. 1992;6:23-25.
46. Kupari M, Koskinen P., Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years: focus on lifestyle and salt intake. Circulation. 1994;89:1041-1050.
47. Avolio AP, Clyde KM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis. 1986;6:166-169.
48. Cianciaruso B, Bellizzi V, Minutolo R, et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24:296-301.
49. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007; 356: 1966-1978.
50. Stamler J, Elliott P, Dennis B, et al. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens. 2003;17:591-608.
51. Yamori Y, Nara Y, Mizushima S, et al. International cooperative study on the relationship between dietary factors and blood pressure; a report from Cardiovascular and Alimentary Comparison (CARDIAL) Study. J Cardiovasc Pharmacol. 1990;16(suppl 8):S43-S47.
52. Yamori Y, Nara Y, Mizushima S, et al. International cooperative study on the relationship between dietary factors and blood pressure: a preliminary report from Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study. Nutr Health. 1992;8:77-90.
53. LIU L, Mizioshima S, Iheda K, et al; on behalf of the China-Japan Cooperative Research Group of the WHO-CARDIAC Study. Comparative studies of diet-related factors blood pressure among Chinese, Japanese: results from the China-Japan Cooperative Research of the WHO-CARDIAC Study. Hypertens Res. 2000;23:413-420.
54. Liu L, Ikedac K, Yine X, et al. Geoethnic-sensitive and cross-culture differences of dietary patterns and blood pressure among five ethnic populations in China. Int Cong Ser. 2004;262:168-172.
55. Miziushima S, Cappucels FP, Nicholes R, Eliott P. Dietary magnesium intake and blood pressure: a quantitative overview of the observational studies. J Hum Hypertens. 1998;12:447-453.
56. Yamori Y, Mizushima S. A review of the link between dietary magnesium and cardiovascular risk. Cardiovasc Risk. 2000;7:31-35.
57. Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys. 2007;458:33-39.
58. Adachi M, Nara Y, Mano M, et al. Intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats and effects of blood pressure and various antihypertensive agents. Clin Exp Pharmacol Physiol. 1993;20:587-593.
59. Adachi M, Nara Y, Mano M, Yamori Y. Effect of dietary magnesium supplementation on intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens. 1994;16:317-326.
60. Hatzistavri LS, Sarafidis PA, Georgianos PI, et al. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens. 2009;22:1070-1075.
61. Takeda R, Nakamura T. Effects of high magnesium intake on bone mineral status and lipid metabolism in rats. J Nutr Sci Vitaminol. 2008;54:66-75.
62. Yamori Y, Taguchi T, Mori H, Mori M. Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. J Biomed Sci. 2010;17(suppl 1):S21.
63. Dixit AA, Azar KMJ, Gardner CD, Palaniappan LP. Incorporation of whole, ancient grains into a modern Asian Indian diet: practical strategies to reduce the burden of chronic disease. Nutr Rev. 2011;69:479-488.